Literature DB >> 22833280

Novel mechanisms of abdominal aortic aneurysms.

Hong Lu1, Debra L Rateri, Dennis Bruemmer, Lisa A Cassis, Alan Daugherty.   

Abstract

Abdominal aortic aneurysms (AAAs) are a common but asymptomatic disease that has high susceptibility to rupture. Current therapeutic options are limited to surgical procedures because no pharmacological approaches have been proven to decrease either expansion or rupture of human AAAs. The current dearth of effective medical treatment is attributed to insufficient understanding of the mechanisms underlying the initiation, propagation and rupture of AAAs. This review will emphasize recent advances in mechanistic studies that may provide insights into potential pharmacological treatments for this disease. While we primarily focus on recent salient findings, we also discuss mechanisms that continue to be controversial depending on models under study. Despite the progress on exploring mechanisms of experimental AAAs, ultimate validation of mechanisms will require completion of prospective double-blinded clinical trials. In addition, we advocate increased emphasis of collaborative studies using animal models and human tissues for determination of mechanisms that explore expansion and rupture of existing AAAs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22833280      PMCID: PMC3436976          DOI: 10.1007/s11883-012-0271-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  122 in total

Review 1.  A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion.

Authors:  Hisato Takagi; Masafumi Matsui; Takuya Umemoto
Journal:  J Vasc Surg       Date:  2010-07-17       Impact factor: 4.268

2.  Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.

Authors:  Antonio Di Gennaro; Dick Wågsäter; Mikko I Mäyränpää; Anders Gabrielsen; Jesper Swedenborg; Anders Hamsten; Bengt Samuelsson; Per Eriksson; Jesper Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

3.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.

Authors:  Stephanie Schulte; Jiusong Sun; Peter Libby; Lindsey Macfarlane; Chongxiu Sun; Marco Lopez-Ilasaca; Guo-Ping Shi; Galina K Sukhova
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

4.  Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.

Authors:  Mingdi Yin; Jian Zhang; Yong Wang; Shaoye Wang; Dittmar Böckler; Zhiquan Duan; Shijie Xin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-06       Impact factor: 8.311

5.  Enhanced abdominal aortic aneurysm formation in thrombin-activatable procarboxypeptidase B-deficient mice.

Authors:  Geoffrey Schultz; Maureen M Tedesco; Eiketsu Sho; Toshihiko Nishimura; Shadi Sharif; Xiaoyan Du; Timothy Myles; John Morser; Ronald L Dalman; Lawrence L K Leung
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

6.  Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.

Authors:  Haruhito A Uchida; Fjoralba Kristo; Debra L Rateri; Hong Lu; Richard Charnigo; Lisa A Cassis; Alan Daugherty
Journal:  Atherosclerosis       Date:  2010-03-04       Impact factor: 5.162

7.  Weight loss in obese C57BL/6 mice limits adventitial expansion of established angiotensin II-induced abdominal aortic aneurysms.

Authors:  Sara B Police; Kelly Putnam; Sean Thatcher; Frederique Batifoulier-Yiannikouris; Alan Daugherty; Lisa A Cassis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-19       Impact factor: 4.733

8.  Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}.

Authors:  Venkateswaran Subramanian; Jonathan Golledge; Talha Ijaz; Dennis Bruemmer; Alan Daugherty
Journal:  Circ Res       Date:  2010-08-26       Impact factor: 17.367

9.  Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms.

Authors:  Milton Hamblin; Lin Chang; Hengmin Zhang; Kun Yang; Jifeng Zhang; Y Eugene Chen
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

10.  Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm.

Authors:  Jonathan Golledge; Bradford Cullen; Catherine Rush; Corey S Moran; Emma Secomb; Frances Wood; Alan Daugherty; Julie H Campbell; Paul E Norman
Journal:  Atherosclerosis       Date:  2009-10-29       Impact factor: 5.162

View more
  25 in total

1.  New ways to dismantle a ticking time bomb: microRNA 712/205 and abdominal aortic aneurysm development.

Authors:  Lars Maegdefessel; Joshua M Spin; Philip S Tsao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07       Impact factor: 8.311

2.  DAPT, a potent Notch inhibitor regresses actively growing abdominal aortic aneurysm via divergent pathways.

Authors:  Chetan P Hans; Neekun Sharma; Rishabh Dev; Jones M Blain; Jeff Tonniges; Gunjan Agarwal
Journal:  Clin Sci (Lond)       Date:  2020-06-26       Impact factor: 6.124

3.  Battle of the bulge: miR-195 versus miR-29b in aortic aneurysm.

Authors:  Joshua M Spin; Philip S Tsao
Journal:  Circ Res       Date:  2014-10-24       Impact factor: 17.367

4.  Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.

Authors:  Nancy R Webb; Maria C De Beer; Joanne M Wroblewski; Ailing Ji; William Bailey; Preetha Shridas; Richard J Charnigo; Victoria P Noffsinger; Jassir Witta; Deborah A Howatt; Anju Balakrishnan; Debra L Rateri; Alan Daugherty; Frederick C De Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

5.  Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms.

Authors:  Andrew Camardo; Dhruv Seshadri; Tom Broekelmann; Robert Mecham; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

6.  Activated invariant natural killer T cells infiltrate aortic tissue as key participants in abdominal aortic aneurysm pathology.

Authors:  Tianyu Miao; Tiehao Wang; Ting Feng; Ding Yuan; Qiang Guo; Fei Xiong; Yi Yang; Lihua Liu; Zhangyu He; Bin Huang; Jichun Zhao
Journal:  Immunology       Date:  2021-08-19       Impact factor: 7.397

7.  Adipocyte-Derived Serum Amyloid A Promotes Angiotensin II-Induced Abdominal Aortic Aneurysms in Obese C57BL/6J Mice.

Authors:  Preetha Shridas; Ailing Ji; Andrea C Trumbauer; Victoria P Noffsinger; Steve W Leung; Adam J Dugan; Sean E Thatcher; Lisa A Cassis; Frederick C de Beer; Nancy R Webb; Lisa R Tannock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-03-28       Impact factor: 8.311

Review 8.  MicroRNA-29b regulation of abdominal aortic aneurysm development.

Authors:  Lars Maegdefessel; Junya Azuma; Philip S Tsao
Journal:  Trends Cardiovasc Med       Date:  2013-07-18       Impact factor: 6.677

Review 9.  Molecular imaging of experimental abdominal aortic aneurysms.

Authors:  Aneesh K Ramaswamy; Mark Hamilton; Rucha V Joshi; Benjamin P Kline; Rui Li; Pu Wang; Craig J Goergen
Journal:  ScientificWorldJournal       Date:  2013-04-23

Review 10.  MicroRNAs: Novel Players in Aortic Aneurysm.

Authors:  Xian-ming Fu; Yang-zhao Zhou; Zhao Cheng; Xiao-bo Liao; Xin-min Zhou
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.